Vitamin E Can Fight Cancer, But Dietary Vitamin E Doesn't Do the Trick
March 26, 2013 8:50 AM
comment(s) - last by
Study suggests special Vitamin E-derived drug will be most effective
is a vitamin used by the human body for
a variety of purposes
. Composed of two groups of fused aromatic rings and a fatty tail, the vitamin commonly occurs in two varieties -- beta and gamma-Tocopherols. Now a new study by
Ohio State University
suggests that vitamin E -- or synthetic analogues -- may be useful in fighting a
broad spectrum of cancers
I. Vitamin E Variants Can Fight Cancer
The new study by
, professor of
medicinal chemistry and pharmacognos
y at The Ohio State University and an investigator in
Ohio State’s Comprehensive Cancer Center
, first examined Vitamin E's role in suppressing
, an enzyme that helps keep cancer cells alive.
, "This is the first demonstration of a unique mechanism of how vitamin E can have some benefit in terms of cancer prevention and treatment."
Akt is associated with keeping a variety of cancer cells alive. It is common in many common cancerous cell types with
gene mutations -- such as prostate cancers. The excess Akt suppress apoptosis (cell death) granting the dangerous cells immortality. But suppressing Akt allows the body's natural processes to trigger death of the tumor cells.
Before you rush to load up on Vitamin E pills beware -- the pills contain mostly alpha and beta-Tocopherols, forms of Vitamin E, which the study found to be less effective in suppressing Akt. By contrast, the gamma form is generally poorly absorbed from dietary supplements and scarcer in pill formulations.
Vitamin E and its derivatives are most effective in fighting cancer.
[Image Source: Wikimedia Commons]
Researchers discovered that by tweaking the structure of the more effective gamma variant -- shortening the fatty acid side chain -- they could get an even more impressive 20-fold increase in Akt suppression.
II. Mechanism of Action Identified, OSU Patents Drug
The researchers explain that the effect occurs when Vitamin E binds to Akt and sequesters it to the fatty lipid bilayer on the cell's inner surface. The complex then attracts
, an anti-tumor agent that binds and inactivates Akt. Professor Chen explains, "This is a new finding. We have been taking vitamin E for years but nobody really knew about this particular anti-cancer mechanism. By reducing two-thirds of the chain, the molecule had a 20 times more potent anti-tumor effect, while retaining the integrity of vitamin E’s head group."
Rodents injected with the Vitamin E-like chemical saw death of prostate cancer tumors, saving their lives. At the same time the agent showed no toxicity or other adverse effects.
AKT1 (left) and AKT2 (right) are common cancer-causing proteins, which the Vitamin E derivatives block. [Image Source: Wikimedia Commons]
While dietary vitamin E is crucial for other purposes, the successful tumor-killing properties of the vitamin E derivative could lead to a new non-toxic cancer therapy via either injections of the drug or ingested absorption. Describes Professor Chen, "Our goal is to develop a safe pill at the right dose that people could take every day for cancer prevention. It takes time to optimize the formulation and the dose."
Ohio State has patented the Vitamin-E derived chemical, indicating that it hopes to commercialize it as a cancer treatment.
The work was funded by government grants from the
National Institutes of Health
, and a paper on the work was
in this month's issue of the peer-reviewed journal
Ohio State Univ.
This article is over a month old, voting and posting comments is disabled
3/26/2013 6:04:16 PM
You chose to analyze just the part where this is coming from government money. I think that sets your bias right there.
"When an individual makes a copy of a song for himself, I suppose we can say he stole a song." -- Sony BMG attorney Jennifer Pariser
Human Skin Cells Used to Create Stem Cells, Treat Brain Disease in Mice
February 8, 2013, 1:25 PM
Scientists Feed Vitamins to Bacteria to Increase Electrical Output
March 4, 2008, 3:20 PM
Biotech, Genetic Engineering and the Boy Who Cried Wolf
September 5, 2007, 11:55 AM
SpaceX Falcon 9's Seventh Supply Mission to ISS Ends w/ Fiery Stage 1 Explosion
June 28, 2015, 1:10 PM
Cool Science Video: Glowing Millipede Prowls the Nevada Desert
May 18, 2015, 12:00 PM
Newly Discovered Costa Rican Glass Frog is Kermit's Doppelgänger
April 22, 2015, 11:26 AM
Researchers Hope to Find "Exotic" Lifeforms Inside Crater of Dinosaur Killing Meteor
April 14, 2015, 8:47 PM
Mathematician's Sociological Formulation May Explain the "Hipster Paradox"
April 14, 2015, 1:13 PM
Cool Science Video: This is What a McDonald's Burger Looks Like in Your Stomach
April 7, 2015, 1:43 PM
Most Popular Articles
F-16 Schools Trillion-Dollar F-35 in Mock Combat, Fleeing is Best Option Pilot Admits
July 1, 2015, 5:53 PM
Apple Music: The Money, The Launch Hiccups, and the Nitty Gritty Details
June 30, 2015, 5:09 PM
Apple iOS 8.4 Rolls Out w/ Fix to Crash-Causing Unicode Text
June 30, 2015, 3:24 PM
Quick Note: Lumia 940 XL "Cityman" Phablet Gets Teased Via Tests
June 29, 2015, 5:51 PM
Microsoft Aims to Be "Customer-Obsessed", "One" Unit, "Diverse and Inclusive"
June 29, 2015, 3:24 PM
Latest Blog Posts
Sceptre Airs 27", 120 Hz. 1080p Monitor/HDTV w/ 5 ms Response Time for $220
Dec 3, 2014, 10:32 PM
Costco Gives Employees Thanksgiving Off; Wal-Mart Leads "Black Thursday" Charge
Oct 29, 2014, 9:57 PM
"Bear Selfies" Fad Could Turn Deadly, Warn Nevada Wildlife Officials
Oct 28, 2014, 12:00 PM
The Surface Mini That Was Never Released Gets "Hands On" Treatment
Sep 26, 2014, 8:22 AM
ISIS Imposes Ban on Teaching Evolution in Iraq
Sep 17, 2014, 5:22 PM
More Blog Posts
Copyright 2015 DailyTech LLC. -
Terms, Conditions & Privacy Information